BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 31159814)

  • 1. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis.
    Wu L; Wang J; Zhu D; Zhang S; Zhou X; Zhu W; Zhu J; He X
    Cancer Biomark; 2020; 27(3):365-375. PubMed ID: 31958073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.
    Plieskatt JL; Rinaldi G; Feng Y; Levine PH; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Bethony JM; Mulvenna JP
    J Transl Med; 2014 Jan; 12():3. PubMed ID: 24393330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
    BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
    Zhuo X; Zhou W; Li D; Chang A; Wang Y; Wu Y; Zhou Q
    Cancer Biomark; 2018; 23(4):579-587. PubMed ID: 30475754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
    Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
    Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
    Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
    Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
    Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.
    Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S
    Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
    Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.
    Lu J; Xu X; Liu X; Peng Y; Zhang B; Wang L; Luo H; Peng X; Li G; Tian W; He M; Li X
    Br J Cancer; 2014 Jan; 110(2):392-8. PubMed ID: 24327016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
    Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.